81 – 90 of 148
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
(
- Contribution to journal › Article
-
Mark
Volumetric modulated arc therapy dose prediction and deliverable treatment plan generation for prostate cancer patients using a densely connected deep learning model
(
- Contribution to journal › Article
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
(
- Contribution to journal › Article
-
Mark
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer : A Dose-Response Study
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
-
Mark
PO-1767 Surface guided FLASH radiotherapy
2021) European Society Radiation Oncology 2021 In Radiotherapy and Oncology 161(Suppl 1). p.1494-1496(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Growth pattern of experimental glioblastoma
(
- Contribution to journal › Article
-
Mark
Ultra-High Dose Rate (FLASH) Radiotherapy : Silver Bullet or Fool's Gold?
(
- Contribution to journal › Scientific review
-
Mark
APM Task Group 329 : Reference dose specification for dose calculations: Dose-to-water or dose-to-muscle?
(
- Contribution to journal › Article
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article